Alliance Opportunities for Aus Biotech
Rasmussen, Bruce (2004) Alliance Opportunities for Aus Biotech. Working Paper. Victoria University, Melbourne, Australia.
Forming alliances between large pharmaceutical and biotechnology companies is an established mechanism to complete the process of development and marketing for a drug initially discovered by a biotechnology company. There is evidence that for most large pharmaceutical companies this process has taken on new urgency as the implications of product pipeline deficiencies are projected to reduce the previously high rates of growth in sales and corporate earnings. Over much of the last decade biotechnology derived medicines have been providing both an increasing number and share of total new medicines approved by the FDA. Therefore it would be surprising if large pharmaceutical companies were not turning increasingly to partnerships with biotechs to generate urgently needed new products.
|Item Type:||Monograph (Working Paper)|
|Uncontrolled Keywords:||pharmaceutical industry; biotechnology companies|
|Subjects:||RFCD Classification > 320000 Medical and Health Sciences
Faculty/School/Research Centre/Department > Centre for Strategic Economic Studies (CSES)
|Depositing User:||Mr Angeera Sidaya|
|Date Deposited:||20 Oct 2005|
|Last Modified:||23 May 2013 16:37|
|ePrint Statistics:||View download statistics for this item|
Repository staff only